Reliant Technologies Receives Two New Patents.FOSTER CITY, Calif.--(HealthWire)--Sept. 17, 1996-- Reliant Technologies, Inc., of Foster City, Calif. has just been granted two new U.S. patents (Nos. 5,546,214 and 5,531,740) related to the control of lasers, via award-winning mirror-based technology, for the advanced treatment of tissue surfaces and venular malformations. Despite the side effects Side effects Effects of a proposed project on other parts of the firm. , millions of laser procedures in dermatology dermatology (dûrmətŏl`əjē), branch of medicine concerned with diagnosis and treatment of diseases and disorders of the skin. and cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. are performed every year, using refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. lens technology to control and focus the laser beam. The side effects from procedures that employ refractive optics technology include excessive thermal injury and scarring. With Reliant's patented technology, the unique and superior reflective optics are used to provide surgeons with greater control of the laser beam than is possible using refractive optics. Reliant's patent No. 5,546,214 is directed to a method and apparatus for treatment of surface with a scanning laser beam having an improved intensity cross-section. The patented device, the AccuScan Laser Scanner, designed for a variety of aesthetic and cosmetic surgeries, scans a laser beam in an Archemedes spiral pattern to controllably ablate ab·late v. To remove or destroy the function of. ablate to remove, especially by cutting. ablate verb To remove; excise the target tissue. Its combination of char-free ablation ablation /ab·la·tion/ (-shun) 1. separation or detachment; extirpation; eradication. 2. removal or destruction, especially by cutting. ab·la·tion n. with layer by layer tissue removal is optimal for high precision applications. Reliant's patent No. 5,531,740 is directed to a method and apparatus for automated color-activated scanning treatment of venular malformations and other dermatological dermatological, dermatologic pertaining to dermatology; of or affecting the skin. conditions, such as port wine stains and spider veins. This patented device uses color-discriminating detectors to activate the laser only when and if the skin is of a pre-determined color. Reliant plans to start production and marketing of this device in the beginning of 1997. Reliant Technologies, Inc. is a privately held corporation Noun 1. privately held corporation - a corporation owned by a few people; shares have no public market close corporation, closed corporation, private corporation , specializing in advanced and innovative laser technology. In the last five years, Reliant has been granted nineteen U.S. patents, many of which involve precision control of laser beam via mirror-based delivery technology, for use in a variety of medical, scientific and industrial applications. In the last few years, Reliant Technologies, Inc. has been recognized as the company that provides the medical industry with devices which allow doctors to achieve the highest level of precision in laser treatments. Reliant now intends to enter discussions with parties interested in using the technology in the above patents. In addition, Reliant is currently seeking additional investors to provide capital to expand Reliant's production and marketing capabilities for the entire Reliant line of products. CONTACT: Reliant Technologies Lana Black, 415/570-6831 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion